IORT for breast cancer stage
innovationMADE BY ZEISS
Providing risk-adapted alternatives for breast-conserving treatments. ZEISS IORT Solutions
innovationMADE BY ZEISS

Breast Cancer

Discover more

Sales Request

Any questions about buying our products?

Contact us now

Price Request

Our Sales Team will contact you shortly.

Request a Quote

Schedule your Consultation

Our experts will contact you shortly.

Schedule an Appointment

Customer Care

Need assistance with your product?

Contact us now

Related Topics

  • 1 Vaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D. J., Keshtgar, M., … Baum, M. (2014). Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. The Lancet, 383(9917), 603–613.
  • 2 Vaidya, J. S., Joseph, D. J., Tobias, J. S., Bulsara, M., Wenz, F., Saunders, C., … Baum, M. (2010). Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. The Lancet, 376(9735), 91–102.
  • 3 Vaidya, J. (2013). “1-stop” radiotherapy could offer an alternative to lengthy and inconvenient post-surgery procedures for breast cancer.
We use cookies on this site. Cookies are small text files that are stored on your computer by websites. Cookies are widely used and help to optimize the pages that you view. By using this site, you agree to their use. more